Gary Bischoping, a partner at private equity firm Hellman & Friedman and former CFO of Finastra and Varian Medical Systems, explains how “operationalizing value creation” can be a “superpower.” Indeed, at Varian, Gary championed a focus on explicit value management, both at corporate and in operations, that redirected their capital allocation priorities, reignited profitable growth, and dramatically increased the share price. Gary refers to himself as a “corporate finance junky,” and he explains the “art” of strategic finance in terms of alignment, rhythm, and truth.
